PDS Biotechnology Cash Flow Statement (2014-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Operating Activities
Net Income (Quarter)	-0.59M	-6.96M	-6.32M	-14.92M	-5.82M	-7.42M	-19.14M	-9.66M	-11.53M	-10.85M	-10.90M	-10.60M	-8.33M	-10.73M	-7.95M	-8.49M	-9.43M	-9.01M	-0.07M	-9.75M
Depreciation and Depletion (Quarter)	0.00M	0.00M	951.00	86.00				0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Share-based Compensation (Quarter)	0.44M	1.70M	1.67M	1.13M	0.49M	0.49M	-3.55M	2.08M	1.30M	0.78M	-5.24M	1.63M	1.80M	1.78M	1.64M	0.20M	0.45M	1.25M	3.90M	1.13M
Gains from Investment Securities (Quarter)
Asset Writedowns and Impairment (Quarter)
Cash from Restructuring (Quarter)
Cash from Operations (Quarter)	0.95M	-5.13M	-4.50M	-6.37M	-5.92M	-5.89M	-7.53M	-13.19M	-4.81M	-7.18M	-8.46M	-9.94M	-8.86M	-8.00M	-8.23M	-9.03M	-9.10M	-5.92M	-3.70M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)						0.07M	0.11M	0.01M	0.12M	0.16M	-0.35M	0.01M	0.28M	0.31M	1.13M	0.01M	0.08M		0.47M	0.27M
Amortization of Deferred Charges (Quarter)	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.06M	0.04M
Depreciation & Amortization (CF) (Quarter)	0.00M	0.00M	951.00	86.00				0.00M	0.00M	0.00M	0.00M	0.00M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Change in Working Capital
Change in Account Payables (Quarter)	1.42M	-0.93M	-0.14M	1.44M	-0.87M	0.16M	-0.82M	0.85M	2.34M	0.95M	1.62M	-0.98M	-2.75M	-1.95M	0.38M	1.17M	1.64M	0.68M	-1.61M
Change in Accured Expenses (Quarter)	-0.39M	0.45M	0.26M	-0.23M	0.34M	0.13M	5.89M	-6.46M	1.52M	0.36M	-1.31M	-0.71M	0.23M	2.53M	-1.64M	-0.07M	-1.31M	0.62M	-1.34M
Other Working Capital Changes (Quarter)	-0.04M	-0.04M	-0.04M	-0.04M	-0.07M	-0.09M	-0.09M	-0.09M	-0.09M	-0.06M
Investing Activities
Capital Expenditures (Quarter)														1.00
Acquisitions (Quarter)
Cash from Investing Activities (Quarter)														-1.00
Financing Activities
Other financing activities (Quarter)	0.22M	0.12M	13.00	0.01M	0.02M		0.12M		0.01M		0.30M				0.77M	2.15M	-2.15M	2.15M	3.17M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)																		1.00M	-1.07M
Change in Capital Stock
Shares Issued (Quarter)	1.20M	2.95M	3.16M	1.33M	0.37M	1.89M	4.17M	5.30M	0.19M	5.38M	5.03M	2.65M	2.30M	0.97M	5.37M	5.35M	0.96M	3.41M	0.19M	9.41M
Net Equity Issued and Repurchased (Quarter)	51.70M						9.86M	4.59M	0.20M	0.80M	10.48M					6.99M	1.50M	1.30M	2.71M
Misc.
Cash from Financing Activities (Quarter)	48.77M	0.12M	13.00	0.01M	0.02M	24.55M	9.71M	4.57M	0.24M	0.80M	10.77M	20.01M	-0.01M	0.02M	0.17M	7.32M	1.00M	0.24M	4.22M
Change in Cash (Quarter)	49.71M	-5.01M	-4.50M	-6.36M	-5.90M	18.66M	2.18M	-8.62M	-4.57M	-6.37M	2.31M	10.07M	-8.90M	-7.98M	-8.06M	-1.71M	-8.11M	-5.67M	0.51M
Free Cash Flow (Quarter)	0.95M	-5.13M	-4.50M	-6.37M	-5.92M	-5.89M	-7.53M	-13.19M	-4.81M	-7.18M	-8.46M	-9.94M	-8.86M	-8.00M	-8.23M	-9.03M	-9.10M	-5.92M	-3.70M
Net Cash Flow (Quarter)	49.71M	-5.01M	-4.50M	-6.36M	-5.90M	18.66M	2.18M	-8.62M	-4.57M	-6.37M	2.31M	10.07M	-8.87M	-7.98M	-8.06M	-1.71M	-8.11M	-5.67M	0.51M

Research Tools

Datasets

Plans

Developers

PDS Biotechnology PDSB Cash Flow Statement (2014-2026)

Research Tools

Datasets

Plans

Developers

PDS Biotechnology PDSB Cash Flow Statement (2014-2026)

Create an account

Sign In

Reset Password